Global Yahoo Advertising Policies

Advertising for nonprescription drugs is acceptable, provided that it complies with these Policies and applicable regulations or guidance issued by the FDA and FTC. Advertisers may be required to submit third-party substantiation concerning such compliance.

Advertising for nonprescription drugs should provide factual information about such products, avoid overstatements of their capabilities and advise consumers to read and follow label directions. Advertisers must include a link to a site that lists the full range of health benefits, risks and other relevant information concerning use of the nonprescription drug.

Advertising for nonprescription drugs is not acceptable in areas directed to kids.

Advertising for nonprescription drugs is acceptable in areas directed to teens but must be approved by the Yahoo Ad Policy team.

Advertising should be confined to those symptoms and conditions for which the product is indicated.

Advertising may not claim or imply that the product can be used for off-label uses. Representations which overstate a product’s effects are unacceptable.

Depictions of before-and-after product use situations should indicate an adequate and accurate time lapse if the product does not provide immediate relief.

Advertising should not portray a casual attitude toward the use of a medication or employ representations associated with the drug culture.

Nonprescription medication may not be equated or compared to prescription drugs. However, a reference to the heritage of a nonprescription drug, which was previously available only by prescription, is permitted.

The words “safe,” “harmless,” “without risk,” or any words or phrases with similar meaning are not acceptable.

Commercial copy should not dramatize distressing symptoms or morbid situations associated with specific illnesses or diseases, nor should it describe internal or external functions of the body in an objectionable manner.

Products that are not expressly subject to an approved FDA new drug application (NDA) may not be advertised as “FDA-approved.”

See Appendix B: Healthcare and Medicines, International Restrictions